The global Human Chorionic Gonadotropin (HCG) market is estimated to be valued at US$ 710.88 million in 2022 and is expected to exhibit a CAGR of 6.5% over the forecast period of 2022-2030. HCG is a hormone produced during pregnancy and is widely used in fertility treatments and weight loss therapies. The market is driven by the increasing prevalence of infertility, growing awareness about HCG therapies, and advancements in medical technology and drug ... Read more
The Human Chorionic Gonadotropin (HCG) Market is estimated to be valued at US$ 757.09 Mn or Mn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Human chorionic gonadotropin or HCG refers to a hormone that supports the normal development of an egg in a woman's ... Read more
